High Court Takes Up Amgen-Sandoz Biosimilar Brawl
The U.S. Supreme Court on Friday took up a fight between Amgen and Sandoz over the obligations of biosimilar makers to give advance notice of sales and divulge approval applications to...To view the full article, register now.
Already a subscriber? Click here to view full article